Conversely, patients experiencing a metabolic challenge, such as obesity, that are unable to respond by increasing PRL levels, are more prone to suffer from metabolic alterations than those upregulating their PRL levels (Figure 1). This evidence concerns the gene PRL and obesity disorder.